- Home
- GALT vs KTWO Comparison
GALT vs KTWO Comparison
Compare GALT & KTWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$2.38
Company Overview
Basic Information| Metric | GALT | KTWO |
|---|---|---|
| Founded | 2000 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 199.2M | 200.2M |
| IPO Year | 2008 | 2026 |
Fundamental Metrics
Financial Performance| Metric | GALT | KTWO |
|---|---|---|
| Price | $2.38 | $9.93 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 303.0K | 2.6K |
| Earning Date | 05-15-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 36.84 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.32 | $9.84 |
| 52 Week High | $7.13 | $10.07 |
Technical Indicators
Market Signals| Indicator | GALT | KTWO |
|---|---|---|
| Relative Strength Index (RSI) | 48.36 | 47.30 |
| Support Level | $2.09 | $9.93 |
| Resistance Level | $2.60 | $10.01 |
| Average True Range (ATR) | 0.22 | 0.04 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 22.92 | 7.14 |
Price Performance
Historical Comparison GALT
KTWO
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About KTWO K2 Capital Acquisition Corporation Class A Ordinary Share
K2 Capital Acquisition Corp is a blank check company.